Recap: Evoke Pharma Q4 Earnings
Evoke Pharma (NASDAQ:EVOK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For March 8, 2022
Companies Reporting Before The Bell
• Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million.
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Trevi Therapeutics (NASDAQ:TRVI) stock moved upwards by 11.9% to $1.41 during Friday's after-market session. The market value of their outstanding shares is at $36.4 million.
Evoke Pharma Offers Commercialization Update For GIMOTI: Received Outcomes From Added Research Study
New Research Study Demonstrates Increased Acceptance Among Healthcare Providers
Patient Testimonial Videos Detail Benefits Included and Available on GimotiRx.com
Expanded Coverage with recent New York Medicaid
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
BioCardia (NASDAQ:BCDA) shares rose 29.91% to $2.91 during Wednesday's after-market session. At the close, BioCardia's trading volume reached 793.9K shares. This is 471.05% of its average volume over the last 100 days. The company's market cap stands at $49.0 million.